No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $19
ITeos Therapeutics Price Target Lowered to $19 From $31 at Wells Fargo
Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $19
H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21
Strategic Focus on Belrestotug Drives Buy Rating for ITeos Therapeutics With Adjusted Price Target of $21
Express News | Iteos Therapeutics Inc : Piper Sandler Cuts Target Price to $16 From $36